MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析

◆英語タイトル:MiMedx Group Inc (MDXG) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH83319FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MiMedx Group Inc (MiMedx) develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation, and enhance healing. The company offers services in the areas of wound care, burn, surgical, orthopaedic, spine, sports medicine, ophthalmic and dental sectors of healthcare. MiMedx is headquartered in Marietta, Georgia, the US.

MiMedx Group Inc Key Recent Developments

Mar 30,2021: MiMedx awarded amniotic tissue supplier agreement with Premier’s SURPASS Purchasing Program
Mar 08,2021: MiMedx announces fourth quarter and full year 2020 financial and operating results
Mar 03,2021: MiMedx to Participate at Upcoming Investor Conferences

This comprehensive SWOT profile of MiMedx Group Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MiMedx Group Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

MiMedx Group Inc – Key Information
MiMedx Group Inc – Overview
MiMedx Group Inc – Key Employees
MiMedx Group Inc – Key Employee Biographies
MiMedx Group Inc – Key Operational Heads
MiMedx Group Inc – Major Products and Services
MiMedx Group Inc – History
MiMedx Group Inc – Company Statement
MiMedx Group Inc – Locations And Subsidiaries
MiMedx Group Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

MiMedx Group Inc – Business Description
MiMedx Group Inc – Corporate Strategy
MiMedx Group Inc – SWOT Analysis
SWOT Analysis – Overview
MiMedx Group Inc – Strengths
MiMedx Group Inc – Weaknesses
MiMedx Group Inc – Opportunities
MiMedx Group Inc – Threats
MiMedx Group Inc – Key Competitors

Section 3 – Company Financial Performance Charts

MiMedx Group Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MiMedx Group Inc, Key Information
MiMedx Group Inc, Key Ratios
MiMedx Group Inc, Share Data
MiMedx Group Inc, Major Products and Services
MiMedx Group Inc, History
MiMedx Group Inc, Key Employees
MiMedx Group Inc, Key Employee Biographies
MiMedx Group Inc, Key Operational Heads
MiMedx Group Inc, Other Locations
MiMedx Group Inc, Subsidiaries
MiMedx Group Inc, Key Competitors
MiMedx Group Inc, SWOT Analysis
MiMedx Group Inc, Ratios based on current share price
MiMedx Group Inc, Annual Ratios
MiMedx Group Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MiMedx Group Inc (MDXG):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Maverick Natural Resources LLC:企業の戦略的SWOT分析
    Maverick Natural Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • OJSC Surgutneftegas:企業の戦略・SWOT・財務分析
    OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report Summary OJSC Surgutneftegas - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • salesforce.com, inc.:企業の戦略・SWOT・財務情報
    salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report Summary salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Hong Kong Jockey Club:企業の戦略的SWOT分析
    The Hong Kong Jockey Club - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • InMed Pharmaceuticals Inc (IN):医療機器:M&Aディール及び事業提携情報
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Da Afghanistan Breshna Sherkat:企業の戦略的SWOT分析
    Da Afghanistan Breshna Sherkat - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Vectura Group Plc (VEC):製薬・医療:M&Aディール及び事業提携情報
    Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • CFF GmbH & Co KG:戦略・SWOT・企業財務分析
    CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary CFF GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • IRX Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary IRX Therapeutics Inc (IRX Therapeutics) is a clinical-stage bioresearch company that develops immunotherapies which reduces the immune suppression. The company provides product that overcomes cancer induced immune suppression and restores anti-tumor response. It offers product IRX-2 which is …
  • Norton Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Norton Healthcare Inc (Norton Healthcare) is a healthcare service provider that offers medical services. The center offers services such as cancer care, bariatric and weight management, diabetes and endocrine, gastroenterology, clinical trials, pain management, bone marrow transplantation, d …
  • Apogee Enterprises Inc (APOG):企業の財務・戦略的SWOT分析
    Apogee Enterprises Inc (APOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tesco Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Tesco Corp (Tesco), a subsidiary of Nabors Industries Ltd, is an oilfield technologies company. It sells and rents top drives and automated pipe handling equipment; and offers tubular services, including related products and accessories sales and aftermarket sales and services. The company o …
  • Baloise Holding Ltd (BALN):企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Carlson Wagonlit Travel:企業の戦略・SWOT・財務情報
    Carlson Wagonlit Travel - Strategy, SWOT and Corporate Finance Report Summary Carlson Wagonlit Travel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Aliancys AG:企業の戦略的SWOT分析
    Aliancys AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Healthsense Inc:医療機器:M&Aディール及び事業提携情報
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Pfenex Inc (PFNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • Cogstate Ltd (CGS):医療機器:M&Aディール及び事業提携情報
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆